Cambridge, MA · Founded 2016 · Privately Held (backing)
Developer of precision therapeutics and tools designed for amyotrophic lateral sclerosis and other neurodegenerative diseases with genetically validated targets. QurAlis is based in Cambridge, MA and was founded in 2016. Its last reported valuation was $178 million in Mar 2023. It has raised $158 million across 4 recorded rounds; the latest was a $20 million early-stage round in Aug 2025.
Last reported valuation
$178.0M
Oct 2026
Priced at
—
Total raised
$158.4M
Last round
Early Stage VC
Aug 2025
Team — not yet on record
No current team members for QurAlis are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of QurAlis with a free account
·The complete investor list: 21 names
·Watch QurAlis: the Monday email on marks, rounds and moves
